• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

列线图对预测黑色素瘤患者前哨淋巴结状态有用吗?

Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?

作者信息

Lourdault Kristel, Cowman Arthur W, Hanes Douglas, Scholer Anthony J, Aguilar Tyler, Essner Richard

机构信息

Saint John's Cancer Institute at Providence St. John's Health Center, Santa Monica, California, USA.

Providence Research Network, Portland, Oregon, USA.

出版信息

J Surg Oncol. 2025 Mar;131(4):685-693. doi: 10.1002/jso.27976. Epub 2024 Nov 17.

DOI:10.1002/jso.27976
PMID:39552276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12065441/
Abstract

BACKGROUND AND OBJECTIVES

Clinical nomograms have been developed to predict sentinel lymph node (SLN) status in early-stage melanoma patients, but the clinical utility of these tools remains debatable. We created and validated a nomogram using data from a randomized clinical trial and assessed its accuracy against the well-validated Melanoma Institute Australia (MIA) nomogram.

METHODS

We developed our model to predict SLN status using logistic regression on clinicopathological patient data from the Multicenter Selective Lymphadenectomy Trial-I. The model was externally validated using the National Cancer Database (NCDB) data set, and its performance was compared to that of the MIA nomogram.

RESULTS

Our model had good discrimination between positive and negative SLNs, with a training set area under the curve (AUC) of 0.706 (0.661-0.751). Our model achieved an AUC of 0.715 (0.706-0.724) compared to 0.723 (0.715-0.731) with the MIA model, using the NCDB set.

CONCLUSION

Our model performed similarly to the MIA model, confirming that despite using different clinical features and data sets, no clinical nomogram is currently accurate enough for clinical use.

摘要

背景与目的

已开发出临床列线图来预测早期黑色素瘤患者前哨淋巴结(SLN)状态,但这些工具的临床实用性仍存在争议。我们利用一项随机临床试验的数据创建并验证了一个列线图,并将其准确性与经过充分验证的澳大利亚黑色素瘤研究所(MIA)列线图进行了评估。

方法

我们使用多中心选择性淋巴结清扫试验-I中患者的临床病理数据,通过逻辑回归开发了预测SLN状态的模型。该模型使用国家癌症数据库(NCDB)数据集进行外部验证,并将其性能与MIA列线图进行比较。

结果

我们的模型在阳性和阴性SLN之间具有良好的区分能力,训练集曲线下面积(AUC)为0.706(0.661-0.751)。使用NCDB数据集时,我们的模型AUC为0.715(0.706-0.724),而MIA模型为0.723(0.715-0.731)。

结论

我们的模型表现与MIA模型相似,证实尽管使用了不同的临床特征和数据集,但目前没有临床列线图准确到足以用于临床。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970f/12065441/66506ad81e07/JSO-131-685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970f/12065441/dc1d51888c5c/JSO-131-685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970f/12065441/66506ad81e07/JSO-131-685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970f/12065441/dc1d51888c5c/JSO-131-685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970f/12065441/66506ad81e07/JSO-131-685-g002.jpg

相似文献

1
Are Nomograms Useful for Predicting Sentinel Lymph Node Status in Melanoma Patients?列线图对预测黑色素瘤患者前哨淋巴结状态有用吗?
J Surg Oncol. 2025 Mar;131(4):685-693. doi: 10.1002/jso.27976. Epub 2024 Nov 17.
2
Using Nomograms Wisely: Predicting Sentinel Node Positivity in Melanoma.明智使用列线图:预测黑色素瘤前哨淋巴结阳性。
Ann Surg Oncol. 2024 Nov;31(12):8240-8244. doi: 10.1245/s10434-024-15891-9. Epub 2024 Aug 13.
3
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.在线前哨淋巴结阳性风险计算器对 T1 和 T2 期黑色素瘤患者管理的影响。
Ann Surg Oncol. 2024 Aug;31(8):5331-5339. doi: 10.1245/s10434-024-15456-w. Epub 2024 May 27.
4
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.一个预测薄型黑色素瘤患者淋巴结阳性的列线图有助于共同的患者决策。
J Surg Oncol. 2019 Dec;120(7):1276-1283. doi: 10.1002/jso.25720. Epub 2019 Oct 10.
5
Sentinel lymph node positivity in melanoma: Which risk prediction tool is most accurate?黑色素瘤前哨淋巴结阳性:哪种风险预测工具最准确?
Surgery. 2024 Oct;176(4):1143-1147. doi: 10.1016/j.surg.2024.05.035. Epub 2024 Jul 11.
6
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.新辅助化疗后前哨淋巴结阳性患者非前哨淋巴结转移的预测因素:预测非前哨淋巴结转移的列线图。
Clin Breast Cancer. 2017 Nov;17(7):550-558. doi: 10.1016/j.clbc.2017.03.014. Epub 2017 Apr 6.
7
Prediction of non-sentinel lymph node metastases in T1-2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy.新辅助治疗后行乳房切除术的 T1-2 前哨淋巴结阳性乳腺癌患者中非前哨淋巴结转移的预测。
World J Surg Oncol. 2024 Sep 28;22(1):258. doi: 10.1186/s12957-024-03537-9.
8
Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.爱尔兰人群中预测黑色素瘤前哨淋巴结状态的列线图的验证
Ir J Med Sci. 2015 Dec;184(4):769-73. doi: 10.1007/s11845-014-1166-4. Epub 2014 Jul 6.
9
Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.预测中国乳腺癌患者中1-2枚前哨淋巴结阳性时非前哨淋巴结转移情况:一种新预测列线图的构建与评估
World J Surg. 2015 Dec;39(12):2919-27. doi: 10.1007/s00268-015-3189-z.
10
[A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node].[预测腋窝前哨淋巴结阳性乳腺癌患者非前哨淋巴结转移的列线图]
Zhonghua Zhong Liu Za Zhi. 2020 Aug 23;42(8):653-659. doi: 10.3760/cma.j.cn112152-20190824-00545.

引用本文的文献

1
Surgical Management of Thick Primary Cutaneous Melanoma in the US.美国原发性厚皮黑色素瘤的手术治疗
Cancer Med. 2025 Feb;14(4):e70578. doi: 10.1002/cam4.70578.

本文引用的文献

1
Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.澳大利亚黑色素瘤研究所前哨淋巴结活检风险预测工具对皮肤黑色素瘤的验证。
Ann Surg Oncol. 2024 Apr;31(4):2737-2746. doi: 10.1245/s10434-023-14862-w. Epub 2024 Jan 12.
2
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.基于人群的 MIA 和 MSKCC 工具预测前哨淋巴结状态的验证。
JAMA Surg. 2024 Mar 1;159(3):260-268. doi: 10.1001/jamasurg.2023.6904.
3
The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients.
在预测黑色素瘤患者 SLN 状态方面,整合 i31-GEP 检测优于 MSKCC 列线图。
Anticancer Res. 2023 Oct;43(10):4511-4516. doi: 10.21873/anticanres.16644.
4
External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.利用国家癌症数据库对澳大利亚黑色素瘤研究所前哨淋巴结转移风险预测工具进行外部验证。
J Am Acad Dermatol. 2023 Nov;89(5):967-973. doi: 10.1016/j.jaad.2023.07.011. Epub 2023 Jul 15.
5
Role of Sentinel Lymph Node Biopsy for Skin Cancer Based on Clinical Studies.基于临床研究的前哨淋巴结活检在皮肤癌中的作用。
Cancers (Basel). 2023 Jun 22;15(13):3291. doi: 10.3390/cancers15133291.
6
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma.提高黑色素瘤患者前哨淋巴结活检的选择。
JAMA Netw Open. 2023 Apr 3;6(4):e236356. doi: 10.1001/jamanetworkopen.2023.6356.
7
Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?MIA 和 MSKCC 列线图是否有助于选择黑色素瘤患者进行前哨淋巴结活检?
J Surg Oncol. 2023 Jun;127(7):1167-1173. doi: 10.1002/jso.27231. Epub 2023 Mar 11.
8
A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.一种用于计算原发性皮肤黑色素瘤前哨淋巴结转移的术前概率的临床决策工具。
Ann Surg Oncol. 2023 Jul;30(7):4321-4328. doi: 10.1245/s10434-023-13220-0. Epub 2023 Feb 25.
9
Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.预测患有皮肤黑色素瘤患者前哨淋巴结转移风险模型的实用性。
JAMA Dermatol. 2022 Jun 1;158(6):680-683. doi: 10.1001/jamadermatol.2022.0970.
10
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.整合 31 基因表达谱与临床病理特征以优化皮肤黑色素瘤前哨淋巴结转移预测。
JCO Precis Oncol. 2021 Sep 13;5. doi: 10.1200/PO.21.00162. eCollection 2021.